产品编号 :
Cas No. :
CAS No. |
1196070-26-4 |
|---|---|
中文名称 |
非博氟拉朋钠 |
英文名称 |
Fiboflapon sodium |
别名 |
GSK2190915 sodium salt | SCHEMBL1254527 | sodium;3-[3-tert-butylsulfanyl-1-[[4-(6-ethoxypyridin-3-yl)phenyl]methyl]-5-[(5-methylpyridin-2-yl)methoxy]indol-2-yl]-2,2-dimethylpropanoate | UNDECYLENIC ACID METHYL ESTER [MI] | Q27266421 | Fiboflapon sodium [U |
标准英文名 |
sodium 3-(3-(tert-butylthio)-1-(4-(6-ethoxypyridin-3-yl)benzyl)-5-((5-methylpyridin-2-yl)methoxy)-1H-indol-2-yl)-2,2-dimethylpropanoate |
分子式 |
C38H42N3NaO4S |
分子量 |
659.83 |
精确分子量 |
659.28 |
SMILES |
CC(C([O-])=O)(C)CC1=C(SC(C)(C)C)C2=CC(OCC3=CC=C(C)C=N3)=CC=C2N1CC4=CC=C(C5=CN=C(OCC)C=C5)C=C4.[Na+] |
标准SMILES |
[Na+].CC(C)(C)SC1C2=CC(=CC=C2N(CC2C=CC(=CC=2)C2=CN=C(C=C2)OCC)C=1CC(C)(C)C([O-])=O)OCC1=CC=C(C)C=N1 |
用途 |
Fiboflapon sodium (GSK2190915; AM-803) is an orally active 5-lipoxygenase-activating protein (FLAP) inhibitor with a binding potency of 2.9 nM for FLAP and an IC50 of 76 nM for inhibition of LTB4 in human blood. |
InChIKey |
NOJNFULGOQGBKB-UHFFFAOYSA-M |
|
|
评论 |
|---|